In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-21 of 21 for your search:
Drug:  donor lymphocytes
Find trials that include:  Any drugs shown
Trial Status:  Active
Start Over
        Show
1.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 12 to 60
Sponsor: Other
Protocol IDs: CIK#2/2007, NMRC/1097/2006, NCT00460694

2.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 60 to 75
Sponsor: Other
Protocol IDs: CN301-XYK-001, NCT01690507

3.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 to 60
Sponsor: Other
Protocol IDs: CN301-XYK-002, NCT01758367

4.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 to 65
Sponsor: Other
Protocol IDs: 2012-0501, NCI-2013-01666, NCT01875237

5.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 8 to 61
Sponsor: Other
Protocol IDs: 307-CTC-DC/CIK-Leukemia, NCT01956630

6.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 to 65
Sponsor: Other
Protocol IDs: Eudract number: 2008-003185-26, NCT01186809

7.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 to 69
Sponsor: Other
Protocol IDs: UCL/10/0241, LRF-09041, EU-21081, CRUK-UCL-PROT4, ProT4 (UCL/10/0241), PROT4, CRUK-UCL-10/0241, NCT01240525

8.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 to 70
Sponsor: Other
Protocol IDs: BRD 10/07-H, NCT01541280

9.

Phase: Phase II
Type: Treatment
Status: Approved-not yet active
Age: 18 to 70
Sponsor: Other
Protocol IDs: UCL/10/0411, NCT01597219

10.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: BrUOG 273, NCT01685606

11.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 13D.127, 2012-104, NCT01871441

12.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 to 75
Sponsor: Other
Protocol IDs: H-1305-6130491, NCT01925118

13.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 13D.352, 2013-031, NCT01982682

14.

Phase: Phase II
Type: Treatment
Status: Active
Age: Not specified
Sponsor: Other
Protocol IDs: STIR Trial, NCT02100891

15.

Phase: Phase I
Type: Treatment
Status: Active
Age: 18 to 70
Sponsor: Other
Protocol IDs: 08-0906, NCT00935597

16.

Phase: Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 2010LS063, MT2010-10, 1009M89012, NCT01385423

17.

Phase: Phase I
Type: Supportive care, Treatment
Status: Active
Age: 18 to 75
Sponsor: NCI, Other
Protocol IDs: BMT243, NCI-2012-00044, SU-01272012-9028, 22626, NCT01523223

18.

Phase: Phase I
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: Pro00003975, NCT01627275

19.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Status: Active
Age: 55 and over
Sponsor: Other
Protocol IDs: Pro00043247, NCT02046122

20.

Phase: Phase I
Type: Supportive care, Treatment
Status: Active
Age: Not specified
Sponsor: Other
Protocol IDs: SCTL141501, PG1061252, NCT02189824

21.

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and older
Sponsor: NCI, Other
Protocol IDs: 021208, NCI-2013-02408, Pro2013002693, P30CA072720, NCT02105116
New Search